Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Università del Piemonte Orientale Home
Italiano
English
Cerca contenuto all’indirizzo Università del Piemonte Orientale
Home
Profili
Unità di ricerca
Apparecchiatura
Progetti
Risultato della ricerca
Validation of the Hamilton Rating Scale for Depression in adults with epilepsy
M. Mula
, A. Iudice
, A. La Neve
, M. Mazza
, S. Mazza
, R. Cantello
, A. M. Kanner
Risultato della ricerca
:
Contributo su rivista
›
Articolo in rivista
›
peer review
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'Validation of the Hamilton Rating Scale for Depression in adults with epilepsy'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Keyphrases
Hamilton Depression Rating Scale (HAM-D)
100%
Adults with Epilepsy
100%
Epilepsy
50%
Patients with Epilepsy
33%
Adult Patients
16%
Area under the Curve
16%
Psychometric Properties
16%
Positive Predictive Value
16%
Receiver Operating Characteristic Analysis
16%
Cronbach's alpha
16%
Negative Predictive Value
16%
Cut-off Score
16%
Quality of Life
16%
Mini
16%
Mood Disorders
16%
Clinical Tool
16%
Psychiatric Comorbidity
16%
Adult Outpatients
16%
Disease Burden
16%
Global Burden
16%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
16%
Nursing and Health Professions
Hamilton Depression Rating Scale
100%
Epilepsy
100%
Predictive Value
33%
Patient with Epilepsy
33%
Cronbach Alpha Coefficient
16%
Outpatient
16%
Area under the Curve
16%
Receiver Operating Characteristic
16%
Psychometry
16%
Mood Disorder
16%
Mini International Neuropsychiatric Interview
16%
Comorbidity
16%
Diseases
16%
Quality of Life
16%
Medicine and Dentistry
Hamilton Rating Scale for Depression
100%
Epilepsy
100%
Patient with Epilepsy
33%
Outpatient
16%
Quality of Life
16%
Psychometry
16%
Mood Disorder
16%
Mini-International Neuropsychiatric Interview
16%
Comorbidity
16%
Diseases
16%
Area under the Curve
16%
Psychology
Rating Scale
100%
Epilepsy
100%
Psychometrics
16%
Quality of Life
16%
Mood Disorder
16%
Psychiatric Comorbidity
16%